Colocalization of Glucocorticoid and Mineralocorticoid Receptors in Human Bone
- 1 August 2001
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 16 (8) , 1496-1504
- https://doi.org/10.1359/jbmr.2001.16.8.1496
Abstract
Osteoporosis is a poorly understood but common complication of glucocorticoid therapy. The actions of glucocorticoids are mediated via glucocorticoid receptors (GRs), but in vitro, glucocorticoids also can bind to mineralocorticoid receptors (MRs). It is not known if MR protein is present in human bone and little is known of GR isoform expression (GRalpha and GRbeta). GR and MR protein expression and possible sites of action were investigated in neonatal rib and adult iliac crest biopsy specimens using antibodies specific for MR, GRalpha, and GRalphabeta. Colocalization [MR GRalpha] [MR GRalphabeta] was performed using fluorescent-conjugated secondary antibodies. GRalpha, GRbeta, and MR show distinct but overlapping patterns of expression, suggesting important functions for each receptor type. Osteoclasts showed no staining for GRalpha but strong staining for GRalphabeta, indicating expression of GRbeta and a specific role in addition to antagonizing the transcriptional activity of GRalpha. MR also was observed in osteoclasts and colocalized with GRalphabeta. Coexpression of MR, GRalpha, and GRalphabeta was seen in osteoblasts. Reverse-transcription-polymerase chain reaction (RT-PCR) of cultured osteoblast RNA confirmed expression of both GRalpha and GRbeta. Osteocytes stained with MR, GRalpha, and GRalphabeta antibodies but to a lesser degree than osteoblasts. In the neonatal rib cartilage, staining for GRalpha, GRalphabeta, and MR was present in approximately one-half of the resting and hypertrophic chondrocytes and in most of proliferating chondrocytes and chondrocytes within the mineralizing matrix. Identification of MR raises the possibility that the physiological and pharmacologic effects of glucocorticoids on bone may be mediated via MR as well as GR and that GRalpha, GRbeta, and MR synergize to influence corticosteroid metabolism in human bone.Keywords
This publication has 27 references indexed in Scilit:
- Mechanism of Bone Loss After Liver Transplantation: A Histomorphometric AnalysisJournal of Bone and Mineral Research, 1999
- Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.Journal of Clinical Investigation, 1998
- Inhibition of mineralocorticoid activity by the β-isoform of the human glucocorticoid receptorThe Journal of Steroid Biochemistry and Molecular Biology, 1997
- Stimulation of neonatal mouse calvarial bone resorption by the glucocorticoids hydrocortisone and dexamethasoneJournal of Bone and Mineral Research, 1996
- Mineralocorticoid hypertension and congenital deficiency of 11β‐hydroxysteroid dehydrogenase in a family with the syndrome of‘apparent’mineralocorticoid excessClinical Endocrinology, 1995
- Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans.Journal of Clinical Investigation, 1995
- Asthma, Glucocorticoids and GrowthAnnals of Medicine, 1994
- Differential regulation of mouse mammary tumor virus-bacterial chloramphenicol acetyltranferase chimeric gene by human mineralocorticoid hormone-receptor complexesThe Journal of Steroid Biochemistry and Molecular Biology, 1991
- Glucocorticoids stimulate resorption in fetal rat parietal bones in vitroJournal of Bone and Mineral Research, 1990
- Spironolactone-reversible rickets associated with 11β-hydroxysteroid dehydrogenase deficiency syndromeThe Journal of Pediatrics, 1986